Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 10,732Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 6Zenara Pharma

02 6ANDA Repository

03 1Accord healthcare

04 6Ajanta Pharma Limited

05 6Alembic Pharmaceuticals Limited

06 6Alkem Laboratories

07 6Amneal Pharmaceuticals

08 6Aurobindo Pharma Limited

09 15H. Lundbeck AS

10 6Hetero Drugs

11 6Intas Pharmaceuticals

12 6Lupin Ltd

13 6MSN Laboratories

14 6Otsuka Chemical Co Ltd

15 6Otsuka Holdings

16 6Prinston

17 6Sandoz B2B

18 6Teva Pharmaceutical Industries

19 6Zydus Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date :

Application Number : 213477

Regulatory Info :

Registration Country : USA

Biophore CB

02

arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date :

Application Number : 213477

Regulatory Info :

Registration Country : USA

Biophore CB

03

arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date :

Application Number : 213477

Regulatory Info :

Registration Country : USA

Biophore CB

04

arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date :

Application Number : 213477

Regulatory Info :

Registration Country : USA

Biophore CB

05

arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 3MG

Packaging :

Approval Date :

Application Number : 213477

Regulatory Info :

Registration Country : USA

Biophore CB

06

arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date :

Application Number : 213477

Regulatory Info :

Registration Country : USA

Biophore CB

07

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date : 2023-01-31

Application Number : 213562

Regulatory Info : DISCN

Registration Country : USA

blank

08

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 2023-01-31

Application Number : 213562

Regulatory Info : DISCN

Registration Country : USA

blank

09

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2023-01-31

Application Number : 213562

Regulatory Info : DISCN

Registration Country : USA

blank

10

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2023-01-31

Application Number : 213562

Regulatory Info : DISCN

Registration Country : USA

blank

11

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 3MG

Packaging :

Approval Date : 2023-01-31

Application Number : 213562

Regulatory Info : DISCN

Registration Country : USA

blank

12

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2023-01-31

Application Number : 213562

Regulatory Info : DISCN

Registration Country : USA

blank

13

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

14

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

15

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

16

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

17

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 3MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

18

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2023-03-17

Application Number : 213512

Regulatory Info : DISCN

Registration Country : USA

blank

19

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

20

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

21

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

22

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

23

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 3MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

24

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : REXULTI

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2015-07-10

Application Number : 205422

Regulatory Info : RX

Registration Country : USA

blank

25

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.25MG

Packaging :

Approval Date : 2022-09-26

Application Number : 213570

Regulatory Info : DISCN

Registration Country : USA

blank

26

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 0.5MG

Packaging :

Approval Date : 2022-09-26

Application Number : 213570

Regulatory Info : DISCN

Registration Country : USA

blank

27

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2022-09-26

Application Number : 213570

Regulatory Info : DISCN

Registration Country : USA

blank

28

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2022-09-26

Application Number : 213570

Regulatory Info : DISCN

Registration Country : USA

blank

29

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 3MG

Packaging :

Approval Date : 2022-09-26

Application Number : 213570

Regulatory Info : DISCN

Registration Country : USA

blank

30

Immuno-Oncology 360
Not Confirmed
arrow
arrow
Immuno-Oncology 360
Not Confirmed

BREXPIPRAZOLE

Brand Name : BREXPIPRAZOLE

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2022-09-26

Application Number : 213570

Regulatory Info : DISCN

Registration Country : USA

blank